California bills · 2025-2026 Regular Session
California SB 418
Health care coverage: prescription hormone therapy and nondiscrimination.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Vetoed
Sponsors
- Menjivar (Democratic)
Cosponsors (2)
Summary
Official abstract published by the California legislature· summary
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care and makes a willful violation of the act's requirements a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law also provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services pursuant to a schedule of benefits.
Existing law sets forth specified coverage requirements for health care service plan contracts and health insurance policies. Existing law generally authorizes a health care service plan or health insurer to use utilization controls to approve, modify, delay, or deny requests for health care services based on medical necessity. Existing law requires health care service plans and health insurers, as specified, within 6 months after the relevant department issues specified guidance, or no later than March 1, 2025, to require all of their staff who are in direct contact with enrollees or insureds in the delivery of care or enrollee or insured services to complete evidence-based cultural competency training for the purpose of providing trans-inclusive health care for individuals who identify as transgender, gender diverse, or intersex.
This bill would require a health care service plan contract or health insurance policy issued, amended, renewed, or delivered on or after the bill's operative date that provides outpatient prescription drug benefits to cover up to a 12-month supply of a United States Food and Drug Administration (FDA) -approved prescription hormone therapy, and the necessary supplies for self-administration, that is prescribed by a network provider within their scope of practice and dispensed at one time, as specified. The bill would make the same prescription hormone therapy a covered benefit under the Medi-Cal program, as specified. The bill would prohibit a plan or an insurer from imposing utilization controls or other forms of medical management limiting the supply of this hormone therapy to an amount that is less than a 12-month supply, but would not prohibit a contract, a policy, or the Medi-Cal program from limiting refills that may be obtained in the last quarter of the plan, policy, or coverage year if a 12-month supply of the prescription hormone therapy has already been dispensed during that year. The bill would exclude a Medi-Cal managed care plan contracting with the State Department of Health Care Services from these requirements. The bill would repeal these provisions on January 1, 2035.
This bill would prohibit a subscriber, enrollee, policyholder, or insured from being excluded from enrollment or participation in, being denied the benefits of, or being subjected to discrimination by, any health care service plan or health insurer licensed in this state, on the basis of race, color, national origin, age, disability, or sex. The bill would define discrimination on the basis of sex for those purposes to include, among other things, sex characteristics, including intersex traits, pregnancy, and gender identity. The bill would prohibit a health care service plan or health insurer from taking specified actions relating to providing access to health programs and activities, including, but not limited to, denying or limiting health care services to an individual based upon the individual's sex assigned at birth, gender identity, or gender otherwise recorded. The bill would prohibit a health care service plan or health insurer, in specified circumstances, from taking various actions, including, but not limited to, denying, canceling, limiting, or refusing to issue or renew health care service plan enrollment, health insurance coverage, or other health-related coverage, or denying or limiting coverage of a claim, or imposing additional cost sharing or other limitations or restrictions on coverage, on the basis of race, color, national origin, sex, age, or disability, as specified. Because a violation of the bill's requirements by a health care service plan would be a crime, the bill would impose a state-mandated local program.
Existing law requires a pharmacist to dispense, at a patient's request, up to a 12-month supply of an FDA-approved, self-administered hormonal contraceptive pursuant to a valid prescription that specifies an initial quantity followed by periodic refills.
This bill would additionally require a pharmacist to dispense, at a patient's request, up to a 12-month supply of an FDA-approved, prescription hormone therapy pursuant to a valid prescription that specifies an initial quantity followed by periodic refills, unless an exception is met.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
This bill would declare that it is to take effect immediately as an urgency statute.
Text versions
- 09/16/25 - Enrolled· Sep 16, 2025
- 09/05/25 - Amended Assembly· Sep 5, 2025
- 07/09/25 - Amended Assembly· Jul 9, 2025
- 06/23/25 - Amended Assembly· Jun 23, 2025
- 04/24/25 - Amended Senate· Apr 24, 2025
- 03/27/25 - Amended Senate· Mar 27, 2025
- 02/18/25 - Introduced· Feb 18, 2025
- SB418
Roll-call votes
State vote data last updated Oct 16, 2026, 12:24 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Sep 11, 2025 Senate | Unfinished Business SB418 Menjivar et al. Urgency Clause Concurrence | pass | Set your home in California to see |
| Sep 10, 2025 House | SB 418 Menjivar Third Reading Urgency By Bonta | pass | Set your home in California to see |
| Aug 29, 2025 House | Do pass. | pass | Set your home in California to see |
| Jul 8, 2025 House | Do pass as amended and be re-referred to the Committee on [Appropriations] | pass | Set your home in California to see |
| Jul 1, 2025 House | Do pass and be re-referred to the Committee on [Business and Professions] | pass | Set your home in California to see |
| May 28, 2025 Senate | 3rd Reading | pass | Set your home in California to see |
| Apr 22, 2025 Senate | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | pass | Set your home in California to see |
| Apr 9, 2025 Senate | Do pass, but first be re-referred to the Committee on [Judiciary] | pass | Set your home in California to see |
Actions
- Mar 2, 2026 · Senate
Veto sustained. - Mar 2, 2026 · Senate
Stricken from file. - Oct 13, 2025 · Senate
In Senate. Consideration of Governor's veto pending. - Oct 13, 2025 · Senate
Vetoed by the Governor. - Sep 22, 2025 · Legislature
Enrolled and presented to the Governor at 2 p.m. - Sep 11, 2025 · Senate
Assembly amendments concurred in. (Ayes 29. Noes 10. Page 2893.) Ordered to engrossing and enrolling. - Sep 11, 2025 · Senate
Urgency clause adopted. - Sep 10, 2025 · Senate
In Senate. Concurrence in Assembly amendments pending. - Sep 10, 2025 · House
Read third time. Urgency clause adopted. Passed. (Ayes 60. Noes 18. Page 3174.) Ordered to the Senate. - Sep 5, 2025 · House
Ordered to third reading. - Sep 5, 2025 · House
Read third time and amended. - Sep 5, 2025 · House
Assembly Rule 69(b)(1) suspended. - Sep 2, 2025 · House
Read second time. Ordered to third reading. - Aug 29, 2025 · House
From committee: Do pass. (Ayes 11. Noes 4.) (August 29). - Aug 20, 2025 · House
August 20 set for first hearing. Placed on APPR. suspense file. - Jul 9, 2025 · House
Read second time and amended. Re-referred to Com. on APPR. - Jul 8, 2025 · House
From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 12. Noes 5.) (July 8). - Jul 2, 2025 · House
From committee: Do pass and re-refer to Com. on B. & P. (Ayes 12. Noes 2.) (July 1). Re-referred to Com. on B. & P. - Jul 2, 2025 · House
Coauthors revised. - Jun 23, 2025 · House
From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. - Jun 5, 2025 · House
Referred to Coms. on HEALTH and JUD. - May 28, 2025 · House
In Assembly. Read first time. Held at Desk. - May 28, 2025 · Senate
Read third time. Passed. (Ayes 28. Noes 10. Page 1307.) Ordered to the Assembly. - May 6, 2025 · Senate
Read second time. Ordered to third reading. - May 5, 2025 · Senate
From committee: Be ordered to second reading pursuant to Senate Rule 28.8. - Apr 29, 2025 · Senate
Set for hearing May 5. - Apr 24, 2025 · Senate
Read second time and amended. Re-referred to Com. on APPR. - Apr 23, 2025 · Senate
From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 11. Noes 1. Page 834.) (April 22). - Apr 10, 2025 · Senate
From committee: Do pass and re-refer to Com. on JUD. (Ayes 9. Noes 0. Page 737.) (April 9). Re-referred to Com. on JUD. - Apr 1, 2025 · Senate
Set for hearing April 22 in JUD. pending receipt. - Mar 28, 2025 · Senate
Set for hearing April 9. - Mar 27, 2025 · Senate
From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH. - Feb 26, 2025 · Senate
Referred to Coms. on HEALTH and JUD. - Feb 19, 2025 · Senate
From printer. May be acted upon on or after March 21. - Feb 18, 2025 · Senate
Introduced. Read first time. To Com. on RLS. for assignment. To print.